Use this link to cite:
https://hdl.handle.net/2183/48147 Screening and validation of novel biomarkers in osteoarticular pathologies by comprehensive combination of protein array technologies
Loading...
Identifiers
Publication date
Authors
Sierra-Sánchez, Álvaro
Garrido-Martín, Diego
Lourido, Lucía
González-González, María
Díez, Paula
Ruiz-Romero, Cristina
Sjöberg, Ronald
Droste, Conrad
De Las Rivas, Javier
Nilsson, Peter
Advisors
Other responsabilities
Journal Title
Bibliographic citation
ierra-Sánchez Á, Garrido-Martín D, Lourido L, González-González M, Díez P, Ruiz-Romero C, Sjöber R, Droste C, De Las Rivas J, Nilsson P, Blanco F, Fuentes M. Screening and validation of novel biomarkers in osteoarticular pathologies by comprehensive combination of protein array technologies. J Proteome Res. 2017 May 5;16(5):1890-1899.
Type of academic work
Academic degree
Abstract
[Abstract] Osteoarthritis (OA) is one of the most prevalent articular diseases. The identification of proteins closely associated with the diagnosis, progression, prognosis, and treatment response is dramatically required for this pathology. In this work, differential serum protein profiles have been identified in OA and rheumatoid arthritis (RA) by antibody arrays containing 151 antibodies against 121 antigens in a cohort of 36 samples. Then the identified differential serum protein profiles have been validated in a larger cohort of 282 samples. The overall immunoreactivity is higher in the pathological situations in comparison with the controls. Several proteins have been identified as biomarker candidates for OA and RA. Most of these biomarker candidates are proteins related to inflammatory response, lipid metabolism, or bone and extracellular matrix formation, degradation, or remodeling.
Description
Editor version
Rights
This document is the Accepted Manuscript version of a Published Article that appeared in final form in Journal of Proteome Research, copyright © American Chemical Society.